⚖️DEA Revokes Prescript Pharmaceuticals' Registration for Violations
Prescript Pharmaceuticals; Decision and Order
Summary
The Drug Enforcement Administration issued an Order of Revocation against Prescript Pharmaceuticals after it violated federal regulations pertaining to the procurement of controlled substances. The order highlights the importance of compliance with the Controlled Substances Act, especially concerning the requirement for obtaining procurement quotas for manufacturing activities, and could set a precedent affecting other registrants.
Agencies
- Justice Department
- Drug Enforcement Administration
Business Impact
$$$ - High
The content outlines serious regulatory violations by Prescript Pharmaceuticals related to the procurement of controlled substances without the required quotas, which may threaten business operations and licensing for other pharmaceutical companies. The revocation of their DEA registration has implications for compliance standards and could impact similar businesses in the industry.